Please use this identifier to cite or link to this item:
http://repo.tma.uz/xmlui/handle/1/3077| Title: | ASSESSMENT OF MAIN LIPID METABOLISM INDICATORS IN PATIENTS WITH CHRONIC PANCREATITIS AND METABOLICALLY ASSOCIATED FATTY LIVER DISEASE |
| Authors: | D FATTY LIVER DISEASE Rakhmatullaeva G. K. Sadullaeva U. A. Abdunazarova Z. A. Tashkent State Medical University |
| Issue Date: | 16-Feb-2026 |
| Abstract: | Abstract The prevalence of metabolic syndrome (MS), non-alcoholic fatty liver disease (NAFLD), and non- alcoholic fatty pancreatic disease (NAFPD) accounts for one-quarter to one-third of the world’s population. It has been proven that the key pathogenetic mechanisms of these conditions are disorders of lipid and carbohydrate metabolism. A high comorbidity between NAFLD and NAFPD has been demonstrated: 67.9% of patients with NAFPD were found to have hepatic steatosis, and 96.8% of patients with NAFLD were diagnosed with pancreatic steatosis. |
| URI: | http://repo.tma.uz/xmlui/handle/1/3077 |
| ISSN: | 2938-3765 |
| Appears in Collections: |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 5.Assessment of main lipid metabolism.pdf | 390.1 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.